Clinical and Immunological Effects of a Reduced Daily Dose of Stavudine among Antiretroviral Naïve HIV-infected Individuals in Dar es Salaam, Tanzania: A Randomized, Controlled Study
Journal: Journal of HIV and AIDS (Vol.1, No. 1)Publication Date: 2015-07-31
Authors : Deus Buma Muhammad Bakari Wafaie Fawzi Ferdinand Mugusi;
Page : 1-7
Keywords : Stavudine; Zidovudine; CD4+cell counts; Adherence;
Abstract
Objectives: To compare the immunological and clinical effects of a further reduction of stavudine dose to 30 mg once-daily with that of a standard zidovudine containing antiretroviral therapy (ART) regimen in a prospective, open-label randomized controlled study. Methods: Naïve HIV infected patients were equally randomized to receive either stavudine 30 mg once-daily or a standard dose zidovudine containing regimen. CD4+ T-cell counts, Haemoglobin (Hb), alanine aminotransferase (ALT), Body Mass Index (BMI), WHO stage and patients' morbidity at baseline, three and six months were determined. Changes between baseline and three as well as six months follow-up were compared within-and between-groups. Results: Five hundred and twenty patients aged ≥ 18 years were included. Males were 159 (30.6%), with the mean (SD) age of 39 (9) years. Within group comparison indicated that there were statistically significant increases in mean CD4+ cell counts, BMI, and Hb (p<0.0001) at 3 and 6 months from the values at baseline in both groups, but there were not significantly different between groups. Furthermore, there was no statistically significant difference between groups in terms of occurrence of opportunistic infections (OIs) however, there was significant decrease of OIs for subsequent follow up time points compared to baseline status. The overall median adherence rate was 94% (IQR 94%, 98%) in both groups, but patients in the stavudine group had better adherence compared to those in the zidovudine group, p<0.0001. Additionally, liver damage at 6 months, as indicated by elevated ALT, was more likely with the zidovudine based regimen, p <0.0001. There was no statistically significant difference in ALT elevations between the groups at 3 months. Conclusion: The immunological and clinical outcomes following a regimen employing a reduced dose of stavudine to 30 mg once-daily were similar to those of a standard zidovudine-based antiretroviral regimen.
Other Latest Articles
- Coreceptor Usage of Syncytium-Inducing- HIV-1 Isolates Depends on the Target Cell and Evolves during Pediatric Infection
- Review of Mustajoki, Arto Samuel, Ekaterina Protassova and Maria N. Yelenevskaya (eds.). 2020. The Soft Power of the Russian Language. Plucentricity, Politics and Policies. Abingdon: Routledge. ISBN 9780367183660
- Review of Ponton, Douglas Mark. 2020. Understanding Political Persuasion: Linguistic and Rhetorical Analysis. Vernon Press. Series in Language and Linguistics
- The Influence of Modern English Loanwords on the Verbal Code of Russian Culture
- Phraseological Preposition afin de in the Customs Discourse: A Case Study of French-Language Customs Press
Last modified: 2020-08-04 00:29:45